Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Shares of Deciphera Pharmaceuticals Rose This Week
Why Shares of Deciphera Pharmaceuticals Rose This Week
Why Shares of Deciphera Pharmaceuticals Rose This Week
Submitted by
admin
on August 13, 2023 - 2:34pm
Source:
Motley Fool
News Tags:
Deciphera
earnings
Qinlock
GIST
Headline:
Why Shares of Deciphera Pharmaceuticals Rose This Week
snippet:
Deciphera saw revenue rise by 17.4% year over year.
The company's only marketed therapy is Qinlock to treat advanced GIST.
The company's pipeline includes 16 programs.
Do Not Allow Advertisers to Use My Personal information
